AbbVie is an American publicly traded biopharmaceutical company founded in 2013. It originated as a spin-off of Abbott Laboratories.
Since our founding in 2013, we've spent more than $50 billion on research to find, develop, and deliver innovative medicines. We focus on diseases where there is a high unmet need and where innovative new medicines can improve the standard of care. We're continuously striving to develop solutions that have a positive impact on patients' lives, societies, and science itself, in addition to curing the sickness.
Today, our 48,000 workers work in immunology, oncology, neuroscience, eye care, virology, and women's health, as well as through our Allergan Aesthetics portfolio, to discover and deliver breakthrough medicines and products in a variety of therapeutic areas.
We genuinely care about our patients and customers, as well as their families, employees, and communities. We try to do the right thing at all times, pursuing the highest quality, compliance, safety, and performance standards. We value people from all walks of life and treat them with dignity and respect, allowing us to all achieve our full potential.
Our dedication to health does not end with our medications. Every day, we strive to provide long-term solutions that benefit both our company and humanity's health.